title: Hypertensive emergencies in pregnancy.
abstract: Hypertensive disorders of pregnancy complicate 7% to 10% of pregnancies and are among the major causes of maternal and perinatal morbidity and mortality. Recently American College of Obstetricians and Gynecologists Taskforce on Hypertension during Pregnancy modified the diagnosis and management of hypertension in pregnancy, recommending prompt diagnosis, admission, close monitoring, and treatment. They strive to decrease maternal mortality and systemic complications. Labetalol, hydralazine, or nifedipine are considered first-line treatment, and either can be used to stabilize the patient with similar outcomes. Definite treatment is delivery of the fetus and should be considered based on the etiology of the hypertensive crisis and gestational age.
authors.affiliation: Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas.
authors.forename: Rakesh B
authors.initials: RB
authors.lastname: Vadhera
authors.forename: Michelle
authors.initials: M
authors.lastname: Simon
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004461:Eclampsia; D004630:Emergencies; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D046110:Hypertension, Pregnancy-Induced / Q000188:drug therapy*; D007741:Labetalol / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D011225:Pre-Eclampsia; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D000959:Antihypertensive Agents; D006830:Hydralazine; D009543:Nifedipine; D007741:Labetalol